SCHEMBL2948145

SCHEMBL2948145

Cc1cc(OC(c2ccc(OC(C)C)cc2)c2n[nH]c(-c3ccc4ccccc4c3)n2)ccc1OCC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.51
PPARA Q07869 4/20 0.45
PPARG P37231 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2946664 0.90 PPARD (0.49) PPARDPPARAPPARG
SCHEMBL5533083 0.88 PPARD (0.41) PPARDPPARA
SCHEMBL2948370 0.87 PPARD (0.49) PPARDPPARAPPARG
SCHEMBL2948560 0.87 PPARD (0.58) PPARDPPARA
SCHEMBL2943306 0.87 PPARD (0.58) PPARDPPARAPPARG
SCHEMBL2946652 0.87 PPARD (0.58) PPARDPPARAPPARG
SCHEMBL2941706 0.86 PPARD (0.51) PPARDPPARA
SCHEMBL2941998 0.86 PPARD (0.60) PPARDPPARAPPARG
SCHEMBL2944584 0.80 PPARD (0.54) PPARDPPARAPPARG
SCHEMBL2946512 0.79 PPARD (0.56) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137591-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-05-28 US claimed
US-7750032-B2 Compounds and compositions as PPAR modulators IRM LLC (BM) 2010-07-06 US disclosed
US-20090137591-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-05-28 US disclosed
EP-1843763-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM, LLC (BM) 2007-10-17 EP disclosed
WO-2006084176-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137591-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS PPARG, PPARD, PPARA PPARD 2/4885PPARA 3/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.